Control Bionics (ASX:CBL)

?? Our CEO, Jeremy Steele, is looking forward to attending the Impact Investment Summit Asia Pacific 2025 and speaking on the panel "Scaling Solutions Helping Young Australians with Disabilities" on Wednesday, 26th March. It’s a great opportunity to discuss how technology-driven innovation can create real impact, expanding access to assistive communication, mobility, and rehabilitation solutions for young Australians. ?? Learn more about the summit: https://lnkd.in/gZdwGnx #ImpactInvesting #ControlBionics #AssistiveTechnology #NeuroTech #MedTech #HealthcareInnovation #Inclusion Kerry Series Kanak Sahasrabudhe Joe Durak Adi Deshpande David Falk Thomas Conn

?? Our CEO Jeremy Steele, CFO Shannon Boothroyd and US team attended the Assistive Technology Industry Association (ATIA) 2025 Conference in Orlando. The industry is excited about new opportunities to access Control Bionics technology, thanks to our newly approved US code under the Healthcare Common Procedure Coding System (HCPCS), which facilitates reimbursement for our #NeuroNode? devices. This milestone achievement in the industry unlocks new distribution potential, making our solutions more accessible to those who need them most. We had several positive meetings with industry leaders and partners at ATIA 2025 as we continue to advance assistive communication and mobility solutions. ATIA is a premier global event for assistive technology manufacturers, developers, and resellers. #ControlBionics #ATIA2025 #AssistiveTechnology #HCPCS #Accessibility #HealthcareInnovation David Falk Thomas Conn Joe Durak Kanak Sahasrabudhe Adi Deshpande Kerry Series Todd Tyler

?? Control Bionics (ASX:CBL) - Q2 FY25 Quarterly Report #ASX announcement with key highlights including: ?? Record U.S. revenue – Nearly US$1 million in sales, driven by growing market penetration. We also received our first HCPCS code reimbursements. ?? First commercial agreements for NeuroStrip?, expanding into U.S. sports performance and Japanese rehabilitation. ?? 30% increase in cash receipts relative to corresponding quarter in FY24, reflecting strong demand and improving collections. ?? Continued cost optimisation, with A$700,000 in annualised savings set to take full effect in H2 FY25. CEO Jeremy Steele commented "This quarter has been one of the most pivotal in Control Bionics’ history... we are demonstrating the scalability of our technology across multiple industries. Our focus remains on accelerating revenue growth, achieving profitability in each of our core markets, and expanding NeuroStrip? into high-potential applications like sports science and health diagnostics. With clear commercialisation pathways, and a growing market presence, we are well-positioned to deliver sustained value for shareholders in 2025 and beyond.” We are excited about the opportunities for our company ahead in 2025. ?? Read the full report here: https://lnkd.in/gNrkdn7m #ControlBionics #QuarterlyUpdate #Neurotechnology #EMG #HealthcareInnovation #AssistiveTechnology $CBL Shannon Boothroyd

Thanks to Stockhead TV for this valuable roundup of our key 2024 achievements and what we're aiming for in 2025. As we continue to diversify our offerings and unlock new opportunities, we’re excited about what’s ahead for Control Bionics in 2025. Jeremy Steele Joe Durak Lindsay Phillips David Falk Kanak Sahasrabudhe Adi Deshpande

Moira's mom, Dania Ermentrout, tells us, "With her device's AI capabilities in ChatCrackers, Moira's creativity knows no bounds." Check out the full blog post here: https://lnkd.in/g-G4aZvn

Control Bionics (ASX:CBL) is launching our partnership with NeuroBounce in Australia in 2025. We'd like to hear from individuals with an exercise science degree or significant training and experience as a strength and conditioning coach. The role will initially be flexible part-time commencing later this month for a 3 month period. The person will need to be Melbourne based. The role will receive training and support on the world class jump program from the US. Further information and how to apply is in the attached document. This is a fantastic opportunity to launch a program that delivers extraordinary results for athletes.

It's not too late to register!! Use the link below!!

We are partnering with Numotion Speech Solutions to provide a free webinar with possible CEU credit on January 7th. Use the information below to register and join us to learn more about Scanning with the NeuroNode Trilogy!

Join us today for our Investor Briefing to hear more about our business update and recent agreements for further global expansion. Register: https://bit.ly/3Bts4rt